Innolet and hypoglycaemic unconsciousness Patient Reports February 12, 2012
Innolet Side Effects Report #5967893-8
Innolet side effect was reported by a Physician from JAPAN on Nov 17, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with type 2 diabetes mellitus and was treated with Innolet. After drug was administered, patient experienced the following side effects: hypoglycaemic encephalopathy, hypoglycaemic unconsciousness. Innolet dosage: unknown. During the same period patient was treated with PLAVIX, LIVALO, MICARDIS, TOFRANIL, ASPIRIN. Patient was hospitalized and became disabled. Patient recovered.
Innolet Side Effects Report #5986358-0
Innolet side effect was reported by a Physician from JAPAN on Nov 28, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with type 2 diabetes mellitus and was treated with Innolet. After drug was administered, patient experienced the following side effects: hypoglycaemic encephalopathy, hypoglycaemic unconsciousness. Innolet dosage: unknown. During the same period patient was treated with PLAVIX, LIVALO, MICARDIS, TOFRANIL, ASPIRIN. Patient was hospitalized and became disabled. Patient recovered.
Innolet Side Effects Report #5965030-7
Innolet side effect was reported by a Physician from JAPAN on Nov 11, 2008. Male patient, weighting 134.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension, insomnia, gastritis, streptococcal identification test, reflux oesophagitis and was treated with Innolet. After drug was administered, patient experienced the following side effects: anti-insulin antibody decreased, catheter related infection, hypoglycaemia, hypoglycaemic unconsciousness, shunt occlusion. Innolet dosage: unknown. During the same period patient was treated with INNOLET R CHU, CARDENALIN, NORVASC, LENDORM, GASLON N, BLOPRESS, PLETAL, TAKEPRON. Patient was hospitalized. Patient recovered.
Innolet Side Effects Report #5979900-7
Innolet side effect was reported by a Physician from JAPAN on Nov 28, 2008. Male patient, weighting 134.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension, insomnia, gastritis, streptococcal identification test, reflux oesophagitis and was treated with Innolet. After drug was administered, patient experienced the following side effects: anti-insulin antibody decreased, anti-insulin antibody increased, hypoglycaemia, hypoglycaemic coma, hypoglycaemic unconsciousness. Innolet dosage: unknown. During the same period patient was treated with INNOLET R CHU, CARDENALIN, NORVASC, LENDORMIN, GASLON N, BLOPRESS, PLETAL, TAKEPRON. Patient was hospitalized. Patient recovered.
Innolet Side Effects Report #6004263-0
Innolet side effect was reported by a Physician from JAPAN on Dec 05, 2008. Male patient, weighting 134.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension, insomnia, gastritis, streptococcal identification test, reflux oesophagitis and was treated with Innolet. After drug was administered, patient experienced the following side effects: anti-insulin antibody decreased, anti-insulin antibody increased, hypoglycaemia, hypoglycaemic coma, hypoglycaemic unconsciousness. Innolet dosage: unknown. During the same period patient was treated with INNOLET R CHU, CARDENALIN, NORVASC, LENDORMIN, GASLON N, BLOPRESS, PLETAL, TAKEPRON. Patient was hospitalized. Patient recovered.
Innolet Side Effects Report #5954895-0
Innolet side effect was reported by a Physician from JAPAN on Nov 11, 2008. Male patient, weighting 134.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension, insomnia, gastritis, streptococcal identification test, reflux oesophagitis and was treated with Innolet. After drug was administered, patient experienced the following side effects: anti-insulin antibody decreased, catheter related infection, hypoglycaemia, hypoglycaemic unconsciousness, shunt occlusion. Innolet dosage: unknown. During the same period patient was treated with INNOLET R CHU, CARDENALIN, NORVASC, LENDORMIN, GASLON N, BLOPRESS, PLETAL, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Innolet and hypoglycaemic unconsciousness 